Inspire Medical Systems, Inc. (INSP) financial statements and ratios from SEC XBRL: revenue $911.98M (TTM), net margin 15.9%, revenue growth 13.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $911.98M |
| Net Margin | 15.9% |
| Revenue Growth (YoY) | 13.6% |
| EPS Growth (YoY) | 175.0% |
| FCF Growth (YoY) | -13.9% |
| EV / EBITDA | 64.5 |
| Price / Book | 2.14 |
| Price / Sales | 2.12 |
| FCF Yield | 3.4% |
| DCF Value (model) | $6.05 |
| DCF Upside vs Price | -90.1% |
| Altman Z-Score | 9.92 (safe) |
| Sector P/E (Healthcare) | 21.6 |
INSP overview · INSP earnings · INSP KPIs · INSP investor relations · INSP ownership · INSP peers · INSP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.